Diabetes and Pregnancy

Slides:



Advertisements
Similar presentations
The Burden of Obesity in North Carolina Obesity-Related Chronic Disease.
Advertisements

Implementing NICE guidance
Dr. Amel F. Al-Sayed Asst. Prof. & Consultant Department of Obstetrics & Gynecology.
 may be efective in preventing SGA birth in women at high risk of preeclampsia although the effect size is small. (c)
Diabetes during pregnancy
Leadership. Knowledge. Community. Canadian Cardiovascular Society Antiplatelet Guidelines USE OF ANTIPLATELET THERAPY IN WOMEN WHO ARE PREGNANT OR BREASTFEEDING.
Diabetes and Pregnancy
MANAGEMENT OF THE OBESE PREGNANT PATIENT Max Brinsmead PhD FRANZCOG May 2010.
VITAL STATISTICS AIM : To reduce maternal, fetal and neonatal deaths related to pregnancy and labour by evaluating the data and taking measures to prevent.
DR. TARIK Y. ZAMZAMI MD, CABOG, FICS ASSOCIATE PROFESSOR CONSULTANT OB/GYN
Presenter Disclosures (1)The following personal financial relationships with commercial interests relevant to this presentation existed during the past.
Diabetes in pregnancy Dr. Lubna Maghur MRCOG. Diabetes is a common medical disorder effecting 2-5% of pregnancies. Diabetes is a common medical disorder.
Normal physiology of pregnancy First trimester-Increased insulin sensitivity. Late 2 nd and 3 rd trimester insulin resistance possible associated with.
Summary: Diet plays a critical role in before, during and after pregnancy. PCOS and Gestational Diabetes are both effected by diet and weight status. Being.
Diabetes in pregnancy James Penny Consultant Obstetrician & Gynaecologist Surrey & Sussex NHS Trust.
The State of Ohio Universal Prenatal Booking David S. McKenna, MD, RDMS Maternal-Fetal Medicine Miami Valley Hospital, Dayton OH.
M.G.S.D. The Gestational Diabetes Study in the Mediterranean Region Protocol C. Savona-Ventura Research Management Committee – M.G.S.D.
PRE-EXISTING DIABETES AND PREGNANCY 2003 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada.
OBesity Project Pregnancy.
Diabetes in Pregnancy Burden of Disease. Diabetes in Pregnancy: Epidemiology 2%-10% of pregnancies currently are complicated by gestational diabetes mellitus.
Neonatal Outcomes of Children Affected by Diabetes Robert Wallerstein, MD Silicon Valley Genetics Center Santa Clara Valley Medical Center.
Diabetes and pregnancy Great Expectations! Sister Lesley Mowat Dr Shirley Copland.
Naghshineh.E MD.  do not have overt vasculopathy  do not have increased risk of congenital malformations 2diabetes in pregnancy.
DIABETES. Type I Diabetes: Preconception Counseling The most important aspect of the management of the Type I diabetic during pregnancy is preconception.
DIABETES IN PREGNANCY DR. SALWA NEYAZI CONSULTANT OBSTETRICIAN GYNECOLOGIST PEDIATRIC & ADOLESCENT GYNECOLOGIST.
Clinical Aspect of Maternal and Child Nursing NUR 363 Lecture 3
Josephine Carlos-Raboca, MD
Camden Diabetes Education Day June 2014
Fetal death in pregnant diabetic women B-Khani Assistant professor of Isfahan University of Medical Science.
Pre-Gestational Diabetes: A Public Health Growth Industry Evan Klass, MD, FACP Associate Dean, Statewide Initiatives Director, Project ECHO-Nevada.
Diabetes in pregnancy Timing and Mode of Delivery
Clinical Aspect of Maternal and Child Nursing NUR 363 Lecture 2
Diabetes during pregnancy. Introduction  Diabetes is a endocrinological disorder.  The prevalence of diabetes is about 3% in the whole population. 
Miss M Maitra Consultant O&G UHCW 29 April What is Diabetes Mellitus? Metabolic disorder Multiple aetiology Chronic hyperglycaemia Defects in insulin.
ANTENATAL CARE OF DIABETES IN PREGNANCY: AUDIT Rachael Read ST2 O&G Supervisor: Mr E Njiforfut Consultant.
Evan Klass, MD, FACP Associate Dean, Statewide Initiatives Director, Project ECHO-Nevada Pre-Gestational Diabetes: A Public Health Growth Industry.
Lifestyle factors associated with preterm births Felicity Ukoko RGN RM MSc Public Health Head of Programmes Wellbeing Foundation Africa.
Racial/Ethnic Disparities in Gestational Diabetes Mellitus in Oregon Monica Hunsberger, MPH, RD, PhD 1, Rebecca J. Donatelle, PhD 2, Kenneth D. Rosenberg,
TEMPLATE DESIGN © Backgroud Methods ResultsConclusions References OPTIONAL LOGO HERE 1.Heslehurst N, Rankin J, Wilkinson.
DM in Pregnancy. DM in pregnancy There are two types of patients having DM in pregnency : There are two types of patients having DM in pregnency : 1-
The FIGO Initiative Setting out a global vision to address hyperglycemia in pregnancy Anil Kapur MD.
Lifestyle factors associated with preterm births
N323: Parent-Child Nursing
CHANGES in ada 2015.
First Antenatal Assessment
Gestational Diabetes: A Big Problem Now and A Bigger Problem Later
Burden of Diabetes in Pregnancy
Ultrasound in hyperglycemia in pregnancy
Linda Yarrow, PhD, RDN, LD, CDE
DIP, GDM; CLINICAL IMPORTANCE AND NEW WHO DIAGNOSTIC CRITERIA FOR GDM
Vital statistics in obstetrics.
Maternal health and the health of Australian Babies
Department of Obstetrics & Gynecology
Overview of Prenatal Care
Intrauterine growth restriction: A new concept in antenatal management
Antenatal care in Hyperglycemia in Pregnancy
Capacity Building for Prevention of Complication from Gestational Diabetes in Public health system, UP Dr Rajesh Jain Project Manager Diabetes Prevention.
Post Partum.
Gestational Diabetes Lab 4.
Pediatric consequences of Assisted Reproductive Technologies
obesITY IN pregnanCY FOR UNDERGRADUATES
Hypertensive Disorders of Pregnancy
First Antenatal Assessment
GESTATIONAL DIABETES RISKS AND FUTURE. GESTATIONAL DIABETES RISKS AND FUTURE.
Epidemiology of Reproductive and Early Years
Obesity and Pregnancy An everyday event
Obstetric Cholestasis (lntrahepatic cholestasis of pregnancy):
Dr. Ed. Barre Professor of Human Nutrition
بسم الله الرحمن الرحيم Management of diabetes in pregnancy.
Chantal Nelson BORN Annual Conference April 25, 2017
Presentation transcript:

Diabetes and Pregnancy Karen Playforth, MFM Associate Professor, Department of OB/GYN September 14th, 2018

I have no conflicts of interest to disclose. Karen Playforth, MD, MFM I have no conflicts of interest to disclose.

St. Luke’s-Roosevelt Hospital: Residency Generalist OB/GYN Attending MFM Fellowship

Overarching Objective Upon completion of this activity, participants will be able to: Explain the potential impact of metabolic syndrome or diabetes on the reproductive health of females

Specific Objectives Upon completion of this activity, participants will be able to: Recognize the importance of preconception counseling in patients with preexisting diabetes mellitus and of post-partum testing and counseling of patients with gestational diabetes mellitus; List the complications of pregnancy associated with poorly controlled preexisting diabetes mellitus in the first trimester of pregnancy; Name the complications of pregnancy common to both preexisting and gestational diabetes mellitus; Describe the baseline lab work and evaluations done in pregnancy for preexisting and gestational diabetes mellitus patients and why; Recall the goals for blood glucose control in pregnancy and why; Restate the recommendations for monitoring and delivery timing for pregnancies complicated by diabetes; Explain the bigger picture of diabetes and the reproductive health of women.

Epidemiology

Epidemiology Approximately 7% of pregnancies are affected by ANY TYPE of diabetes Preexisting diabetes complicates ~1 % of pregnancies in US Type 1 DM accounts for 5-10% of patients diagnosed with diabetes in the general population Incidence of Type 2 DM is very dependent on the population studied Gestational diabetes (GDM) accounts for 86% of diabetes in pregnancy The incidence depends on the baseline prevalence of Type II of the population, which can vary between 1 – 14%. However, type 1 diabetes may represent a slightly greater fraction of women in the reproductive age group because of the relatively earlier age of onset of type 1 diabetes compared with type 2 diabetes Yang JE, Cummings EA, O'Connell C, Jangaard K: Fetal and neonatal outcomes of diabetic pregnancies. Obstet Gynecol 2006. ACOG Practice Bulletin Number 190, February 2018. ACOG Practice Bulletin Number 60, March 2005.

Epidemiology Total of 30.2 million people, or 12.2% of the U.S. population, have diabetes 23 million people with diagnosed diabetes 7.2 million people with undiagnosed diabetes 14.9 million, or 11.7 %, of all women age 18 years or older have diabetes 11.7% of women > 18yo are diagnosed 3.1% of women > 18yo are undiagnosed Data source: 2011–2014 National Health and Nutrition Examination Survey and 2015 U.S. Census Bureau data.

11.1% of Kentucky women are diagnosed with diabetes Data source: 2011–2014 National Health and Nutrition Examination Survey and 2015 U.S. Census Bureau data.

Epidemiology Risk Factors for Diabetes Obesity Sedentary lifestyle Family history Genetics Ethnicity Age INTRAUTERINE ENVIRONMENT

Epidemiology Exponential rise in numbers of pregnancies affected by diabetes mellitus  “Diabesity”  infants of mothers with diabetes (Type 1)  diabetes/prediabetes in reproductive age women 5% to 10% of women with GDM develop Type 2 immediately after pregnancy 35% to 60% of women with GDM develop Type 2 within the 10–20 years Among Hispanic women, approximately 50% develop Type 2 within 2 years 2009 CDC Data

Complications and Interventions

Complications in Pregnancy

Complications in First Trimester

Complications in 1st Trimester Uncontrolled preexisting DM in first trimester of pregnancy = Maternal hyperglycemia Miscarriage Congenital anomalies Open neural tube defects Heart defects

Teratogens MAJOR POINT– Most sensitive time for majority of organs is the EMBRYONIC PERIOD. 3-8 WEEKS.

Interventions in First Trimester (or before) Preconception counseling Risk to fetus for congenital malformations highest often before they know they are pregnant HgbA1c > 8% risk of miscarriage is 26 times baseline risk HgbA1c > 10% confers 25% risk of congenital malformation The pivotal time is 3-6 weeks post-conception, OR 5-8 weeks from LMP.

Interventions in 1st Trimester Diabetes Re-Education  Different rules in pregnancy First trimester Ultrasound to establish dates Baseline labs and evaluations 24 hour urine protein, preeclampsia labs, TSH, maternal echo, ophthalmology exam Start daily low dose aspirin between 12-16 weeks of pregnancy and continue until delivery

Complications in 2nd and 3rd Trimester

Complications in 2nd and 3rd Trimester Uncontrolled DM in second and third trimester of pregnancy = Hyperglycemia and Hyperinsulinemia Premature delivery Preeclampsia Stillbirth Macrosomia Shoulder dystocia Operative delivery Maternal or fetal trauma NICU admission Childhood obesity and diabetes mellitus

Fractured clavicle Erb’s Palsy

In a study done on mothers and infants born at The Ohio State University Hospitals from 1994-1996, 36% of A1 diabetes patient went to the NICU 68% of class D-R diabetics 36% of those going to the NICU for RDS had mechanical ventilation HMD=hyaline membrane disease PPHNB=persistent pulmonary hypertension Arch Pediatr Adolesc Med. 1998;152(3):249-254. doi:10.1001/archpedi.152.3.249

Interventions in 2nd and 3rd Trimester Strict blood glucose control Fasting < 95mg/dl (I prefer <90mg/dl) Pre-prandial <100mg/dl Post-prandial <120mg/dl Bedtime <100mg/dl Close follow-up Nutritional Counseling and Diabetes Self-Management Education Serial ultrasounds for anatomic survey and then for growth q 4 weeks Antenatal testing Delivery timing

Antepartum Testing Ultrasounds Fetal echocardiogram For dating To assess for congenital malformations Growth assessment Fetal echocardiogram Non-Stress Tests – begun generally between 32-34 weeks, but individualized based on underlying risk

Delivery Timing Balance the risk of IUFD with risks of preterm birth Poorly controlled – delivery between 37-39 weeks Evidence of compromise/elevated risk profile – consider delivery before 39 weeks Well-controlled, A1’s may go to EDC Expectant management beyond is not recommended

PREGNANCY = TEACHABLE MOMENT

Questions?